Marchex (NASDAQ:MCHX) Coverage Initiated at StockNews.com

Stock analysts at StockNews.com started coverage on shares of Marchex (NASDAQ:MCHX - Get Free Report) in a research report issued to clients and investors on Sunday. The firm set a "hold" rating on the technology company's stock.

Marchex Trading Up 2.8 %

Marchex stock opened at $1.86 on Friday. The stock has a 50-day moving average price of $1.77 and a 200 day moving average price of $1.53. The company has a market capitalization of $81.24 million, a price-to-earnings ratio of -12.40 and a beta of 1.97. Marchex has a 52 week low of $1.11 and a 52 week high of $2.16. The company has a quick ratio of 2.37, a current ratio of 2.37 and a debt-to-equity ratio of 0.01.

Marchex (NASDAQ:MCHX - Get Free Report) last announced its quarterly earnings data on Thursday, August 8th. The technology company reported ($0.02) EPS for the quarter, meeting the consensus estimate of ($0.02). The business had revenue of $12.07 million during the quarter, compared to analysts' expectations of $12.14 million. Marchex had a negative net margin of 10.03% and a negative return on equity of 11.33%. During the same period in the previous year, the business posted ($0.05) EPS. Sell-side analysts anticipate that Marchex will post -0.08 EPS for the current year.

Hedge Funds Weigh In On Marchex

A hedge fund recently raised its stake in Marchex stock. P.A.W. Capital Corp boosted its stake in shares of Marchex, Inc. (NASDAQ:MCHX - Free Report) by 14.6% in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 400,000 shares of the technology company's stock after acquiring an additional 51,000 shares during the quarter. Marchex accounts for 1.5% of P.A.W. Capital Corp's holdings, making the stock its 13th largest position. P.A.W. Capital Corp owned approximately 0.92% of Marchex worth $616,000 as of its most recent filing with the Securities and Exchange Commission. Institutional investors and hedge funds own 73.46% of the company's stock.

About Marchex

Marchex, Inc, a conversation intelligence company, provides conversational analytics and related solutions in the United States, Canada, and internationally. Its products include Marketing Edge that identifies which campaigns and channels are driving inbound conversations, evaluates what happens during those conversations, and closes the sales loop by connecting converted sales to marketing driven leads; Sonar Business Text Messaging, an artificial intelligence (AI) empowered intelligent workflow enabled mobile messaging solution that enables operations, sales, and marketing teams to communicate personally with field staff, prospects, and customers; Marchex Platform Services, a robust API-based conversation intelligence product that allows executives, sales, customer engagement, and marketing teams to apply Marchex AI to most any calls, regardless of communication platform, in order to identify actionable insights from conversations with their customers; Spotlight, an AI conversation analytics product for multi-location businesses; and Engage, a solution that provides locations with applications to enhance their overall performance.

Read More

• Five stocks we like better than Marchex
• Stock Market Upgrades: What Are They?
• Can Celsius Stock Rebound? Analysts See 74% Upside Potential
• How to Invest in the FAANG Stocks
• Kroger Stock is a Win-Win for Buy-and-Hold Investors
• Basic Materials Stocks Investing
• MarketBeat Week in Review – 9/9 - 9/13

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

→ The #1 Altcoin for September 2024 (From Crypto 101 Media) (Ad)

Should you invest $1,000 in Marchex right now?

Before you consider Marchex, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Marchex wasn't on the list.

While Marchex currently has a "hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here